Status™ COVID-19/Flu A&B Rapid Test
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens.
- COVID-19
- – Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
- – Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%
- Flu A – Sensitivity 91.4%, Specificity 95.7%
- Flu B – Sensitivity 87.6%, Specificity 95.9%
- FDA Emergency Use Authorization (EUA)
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
$340.00
Reviews
There are no reviews yet.